glp-1 rekulo receptor agonists and next-generation metabolic hormone therapies in chronic kidney disease GLP-1R Agonists for Weight Loss

doi: 10.1111/dom.12849 153 WhartonSCalannaSDaviesMDickerDGoldmanBLingvayIet al

In summary, HFimpEF represents a significant and unique subset of heart failure patients compared to those with persistent HFrEF

It became available in the US under the brand-name Wegovy Tablet in early 2026

Policy Obesity is a disease that increases your risk for serious health issues

This review aims to consolidate the current knowledge on PH associated with UGIT surgery, focusing on its epidemiology, clinical manifestations, pathophysiology, diagnostic methods, and management strategies, to provide clinicians with a clearer understanding of this condition and guide improvements in patient care

FTC Affiliate Disclosure: This is paid advertorial content containing affiliate links